FDA Approves Portable Noninvasive Cardiac Output Monitoring

 

January 22, 2008

January 22, 2008 – The FDA cleared by Cheetah Medical Inc.'s Reliant portable cardiac output monitor, designed to provide a noninvasive window to cardiac and hemodynamic function.

The Reliant monitor is powered by Cheetah's unique, patented BIOREACTANCE Technology, which has been used effectively in over 1,000 patients in various clinical settings including hemodynamic monitoring, heart failure, perioperative care, hemodialysis and stress testing.

Reliant uses the NICOM system, which combines traditional impedance technology with BIOREACTANCE Technology. Traditional bioimpedance analyzes changes in voltage of electrical currents traversing the patient’s chest, while BIOREACTANCE also analyzes frequency related effects. NICOM’s hybrid analysis is engineered to deal with electrical noise interference, patient movement, respiration and electrode misplacement and measure cardiac function and hemodynamic status.

For more information: www.cheetah-medical.com

The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.